| 69.15 0.52 (0.76%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 81.21 | 1-year : | 94.85 |
| Resists | First : | 69.52 | Second : | 81.21 |
| Pivot price | 68.18 |
|||
| Supports | First : | 66.95 | Second : | 65.37 |
| MAs | MA(5) : | 68.59 |
MA(20) : | 67.65 |
| MA(100) : | 66.26 |
MA(250) : | 63.55 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 81.7 |
D(3) : | 76.6 |
| RSI | RSI(14): 65.4 |
|||
| 52-week | High : | 69.55 | Low : | 55.36 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IHE ] has closed below upper band by 19.8%. Bollinger Bands are 10.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 69.46 - 69.73 | 69.73 - 70 |
| Low: | 68.19 - 68.52 | 68.52 - 68.84 |
| Close: | 68.63 - 69.12 | 69.12 - 69.62 |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Wed, 24 Jul 2024
IHE: Significant Growth Ahead, But Valuation Not Cheap (Rating Downgrade) - Seeking Alpha
Tue, 18 Jun 2024
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
Tue, 07 May 2024
A Look at Pharma ETFs Post Q1 Earnings - Yahoo Finance
Wed, 01 May 2024
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook - Yahoo Finance
Wed, 17 Apr 2024
The 5 Best Pharmaceutical ETFs of 2023 - etf.com
Fri, 05 Apr 2024
Best Health Care ETFs: Top Biotech, Pharma And Medical Funds - Bankrate.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|